• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《平价医疗法案》在全国实施后,阿片类药物使用障碍患者的治疗使用情况、支付来源及治疗的经济障碍。

Treatment use, sources of payment, and financial barriers to treatment among individuals with opioid use disorder following the national implementation of the ACA.

作者信息

McKenna Ryan M

机构信息

Department of Health Management and Policy, Dornsife School of Public Health, Drexel University, 3215 Market Street, Nesbitt Hall 3rd Floor, Philadelphia, PA 19104, USA.

出版信息

Drug Alcohol Depend. 2017 Oct 1;179:87-92. doi: 10.1016/j.drugalcdep.2017.06.028. Epub 2017 Jul 24.

DOI:10.1016/j.drugalcdep.2017.06.028
PMID:28763780
Abstract

INTRODUCTION

Despite increasing rates of opioid misuse and hospitalizations, rates of treatment for those with opioid use disorder (OUD) are very low. This study examined the impact of the Patient Protection and Affordable Care Act's (ACA) insurance expansion on improving rates of insurance, health care access, and treatment for those with OUD.

METHODS

Data on individuals ages 18-64 with OUD come from the 2008-2014 National Survey on Drug Use and Health (N=4100). Multivariable logistic regression analyses were performed to estimate the trends of health care insurance, treatment and barriers to care across the stages of ACA implementation: pre-ACA (2008-2009), partial-ACA (2010-2013), and national implementation (2014). All models were adjusted for predisposing, enabling, and need factors.

RESULTS

In both adjusted and unadjusted comparisons, national implementation of the ACA was associated with significant improvements in outcome measures for those with OUD. Multivariable analyses indicate that, after national implementation, those with OUD were significantly less likely to be uninsured and were less likely to report financial barriers as a reason for not receiving substance use treatment, relative to the pre-ACA period. Individuals were also more likely to receive substance use treatment and were more likely to report that insurance paid for treatment after national implementation of the ACA relative to the pre-ACA period. These results persisted when national implementation was compared relative to partial-implementation.

CONCLUSIONS

National implementation of the ACA has helped to reduce rates of uninsurance, barriers to care, and improve rates of substance use treatment for those with OUD.

摘要

引言

尽管阿片类药物滥用和住院率不断上升,但阿片类药物使用障碍(OUD)患者的治疗率却非常低。本研究考察了《患者保护与平价医疗法案》(ACA)保险扩展对提高OUD患者的保险覆盖率、医疗保健可及性及治疗率的影响。

方法

有关18至64岁OUD患者的数据来自2008 - 2014年全国药物使用和健康调查(N = 4100)。进行多变量逻辑回归分析,以估计在ACA实施各阶段(ACA实施前(2008 - 2009年)、部分实施ACA阶段(2010 - 2013年)和全面实施阶段(2014年))的医疗保险、治疗及医疗障碍的趋势。所有模型均针对易患因素、促成因素和需求因素进行了调整。

结果

在调整和未调整的比较中,ACA的全面实施都与OUD患者结局指标的显著改善相关。多变量分析表明,在全面实施后,与ACA实施前相比,OUD患者未参保的可能性显著降低,因经济障碍而未接受药物使用治疗的可能性也降低。与ACA实施前相比,在ACA全面实施后,个体接受药物使用治疗的可能性更大,且更有可能报告保险支付了治疗费用。与部分实施阶段相比,全面实施阶段时这些结果依然成立。

结论

ACA的全面实施有助于降低OUD患者的未参保率、医疗障碍,并提高药物使用治疗率。

相似文献

1
Treatment use, sources of payment, and financial barriers to treatment among individuals with opioid use disorder following the national implementation of the ACA.《平价医疗法案》在全国实施后,阿片类药物使用障碍患者的治疗使用情况、支付来源及治疗的经济障碍。
Drug Alcohol Depend. 2017 Oct 1;179:87-92. doi: 10.1016/j.drugalcdep.2017.06.028. Epub 2017 Jul 24.
2
Insurance Coverage and Treatment Use Under the Affordable Care Act Among Adults With Mental and Substance Use Disorders.《平价医疗法案》下患有精神疾病和物质使用障碍的成年人的保险覆盖范围及治疗利用情况
Psychiatr Serv. 2017 Jun 1;68(6):542-548. doi: 10.1176/appi.ps.201600182. Epub 2017 Jan 17.
3
Trends in insurance coverage and treatment among persons with opioid use disorders following the Affordable Care Act.《平价医疗法案》实施后阿片类药物使用障碍患者的保险覆盖范围及治疗趋势
Drug Alcohol Depend. 2017 Oct 1;179:271-274. doi: 10.1016/j.drugalcdep.2017.07.015. Epub 2017 Aug 9.
4
The Affordable Care Act's Dependent Care Coverage Expansion and Behavioral Health Care.《平价医疗法案》的受抚养人护理保险覆盖范围扩大与行为健康护理
J Ment Health Policy Econ. 2017 Sep 1;20(3):111-130.
5
Health Care Access and Utilization Among U.S. Immigrants Before and After the Affordable Care Act.美国平价医疗法案前后移民的医疗保健可及性和利用情况。
J Immigr Minor Health. 2019 Apr;21(2):211-218. doi: 10.1007/s10903-018-0741-6.
6
Insurance Coverage and Utilization Improve for Latino Youth but Disparities by Heritage Group Persist Following the ACA.《ACA 实施后,拉美裔青年的保险覆盖范围和利用率有所提高,但不同族裔群体之间仍存在差异》
Med Care. 2018 Nov;56(11):927-933. doi: 10.1097/MLR.0000000000000992.
7
Why Uninsured Free Clinic Patients Don't Apply for Affordable Care Act Health Insurance in a Non-expanding Medicaid State.为何在非医疗补助扩大州,未参保的免费诊所患者不申请《平价医疗法案》医保。
J Community Health. 2016 Feb;41(1):119-26. doi: 10.1007/s10900-015-0076-3.
8
Barriers to Health Insurance Pre- and Post-Affordable Care Act Implementation in Providence, RI.罗德岛州普罗维登斯市《平价医疗法案》实施前后的医疗保险障碍
R I Med J (2013). 2015 Dec 1;98(12):35-9.
9
Excess Deaths Among the Uninsured Before the Affordable Care Act (ACA), and Potential Post-ACA Reductions.《平价医疗法案》(ACA)实施之前未参保人群中的超额死亡情况以及ACA实施后可能的死亡人数减少情况。
J Public Health Manag Pract. 2017 May/Jun;23(3):e18-e28. doi: 10.1097/PHH.0000000000000428.
10
Adults who misuse opioids: Substance abuse treatment use and perceived treatment need.阿片类药物滥用成年人:药物滥用治疗的使用和治疗需求的认知。
Subst Abus. 2019;40(2):247-255. doi: 10.1080/08897077.2019.1573208. Epub 2019 Feb 27.

引用本文的文献

1
How Does Medicaid Managed Care Address the Needs of Beneficiaries with Opioid Use Disorders? A Deep Dive into Contract Design.医疗补助管理式医疗如何满足阿片类药物使用障碍受益人的需求?深入研究合同设计。
Am J Law Med. 2023 Jul;49(2-3):339-348. doi: 10.1017/amj.2023.35. Epub 2024 Feb 12.
2
Association of Medicaid expansion with health insurance, unmet need for medical care and substance use disorder treatment among people who inject drugs in 13 US states.美国 13 个州中接受医疗补助扩张计划的人在医疗保险、未满足的医疗需求和物质使用障碍治疗方面的关联。
Addiction. 2024 Mar;119(3):582-592. doi: 10.1111/add.16383. Epub 2023 Dec 5.
3
Patient brokering in for-profit substance use disorder treatment: a qualitative study with people with opioid use disorder and professionals in the field.
营利性物质使用障碍治疗中的患者中介:一项针对阿片类药物使用障碍患者和该领域专业人士的定性研究。
BMC Health Serv Res. 2023 Nov 6;23(1):1214. doi: 10.1186/s12913-023-10217-z.
4
Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable Naltrexone.参与丁丙诺啡与纳曲酮注射剂试验后阿片类药物戒断的患者特征。
Subst Use Misuse. 2022;57(11):1732-1742. doi: 10.1080/10826084.2022.2112230. Epub 2022 Aug 17.
5
Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment System.改善阿片类物质使用障碍患者获得循证医学治疗的途径:应对治疗系统中关键障碍的策略
NAM Perspect. 2020 Apr 27;2020. doi: 10.31478/202004b. eCollection 2020.
6
Buprenorphine prescriber monthly patient caseloads: An examination of 6-year trajectories.丁丙诺啡类物质处方者每月患者病例数:对 6 年轨迹的考察。
Drug Alcohol Depend. 2021 Nov 1;228:109089. doi: 10.1016/j.drugalcdep.2021.109089. Epub 2021 Sep 22.
7
Financial sustainability of payment models for office-based opioid treatment in outpatient clinics.门诊诊所基于办公室的阿片类药物治疗支付模式的财务可持续性。
Addict Sci Clin Pract. 2021 Jul 5;16(1):45. doi: 10.1186/s13722-021-00253-7.
8
Black clients in expansion states who used opioids were more likely to access medication for opioid use disorder after ACA implementation.在《平价医疗法案》实施后,使用阿片类药物的扩张州的黑人患者更有可能获得阿片类药物使用障碍的药物治疗。
J Subst Abuse Treat. 2022 Feb;133:108533. doi: 10.1016/j.jsat.2021.108533. Epub 2021 Jun 11.
9
Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse.药物治疗阿片类药物使用障碍试验后的自然随访:药物状况、阿片类药物使用和复发。
J Subst Abuse Treat. 2021 Dec;131:108447. doi: 10.1016/j.jsat.2021.108447. Epub 2021 Apr 30.
10
Growing racial/ethnic disparities in buprenorphine distribution in the United States, 2007-2017.2007-2017 年美国丁丙诺啡分布的种族/民族差异日益扩大。
Drug Alcohol Depend. 2021 Jun 1;223:108710. doi: 10.1016/j.drugalcdep.2021.108710. Epub 2021 Apr 20.